Citation Impact
Citing Papers
Physical Activity and Public Health
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Oral antiplatelet therapy for acute ischaemic stroke
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2008
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
1995 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Comparison of Two Methods to Detect Publication Bias in Meta-analysis
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
1997
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
2011 Standout
Characteristics of cerebrovascular accidents after percutaneous coronary interventions
2004
Prophylaxis for Thromboembolism in Hospitalized Medical Patients
2007
Antithrombotic Therapy for VTE Disease
2016 Standout
Endotoxin‐Stimulated Human Monocyte Secretion of Interleukin 1, Tumour Necrosis Factor Alpha, and Prostaglandin E2 Shows Stable Interindividual Differences
1988
Non-specific low back pain
2016 Standout
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy
2009
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Inflammatory arthritis in caspase 1 gene–deficient mice: Contribution of proteinase 3 to caspase 1–independent production of bioactive interleukin‐1β
2009
Guidelines on the use and monitoring of heparin
2006
Stroke
2008 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Bladder cancer
2016 Standout
Dose-response of physical activity and low back pain, osteoarthritis, and osteoporosis
2001
The Effect of a Mensendieck Exercise Program as Secondary Prophylaxis for Recurrent Low Back Pain
1999
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Antiplatelet therapy for acute ischaemic stroke
2003
Role of the Mononuclear Phagocyte System in the Immunopathogenesis of Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome
1988
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy
1996
Conservative Treatment of Acute and Chronic Nonspecific Low Back Pain
1997
Low Back Pain
2001 Standout
Production of Cytokines by Peripheral Blood Monocytes/Macrophages Infected with Human Immunodeficiency Virus Type I (HIV-I)
1990
Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals
1994
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Non-specific low back pain
2011 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010
2007
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Randomized Trial of Low Molecular Weight Heparin (Dalteparin) in Prevention of Left Ventricular Thrombus Formation and Arterial Embolism After Acute Anterior Myocardial Infarction: The Fragmin in Acute Myocardial Infarction (FRAMI) Study 11This study was supported by grants from the Norwegian Council on Cardiovascular Diseases, Oslo, Norway and Pharmacia AB, Stockholm, Sweden.
1997
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses
2000
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus.
1989
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
1999 Standout
Cells with dendritic morphology and bright interleukin-lα staining circulate in the blood of patients with rheumatoid arthritis
1990
A Novel Approach to Arterial Thrombolysis
1999
Solvent polymeric membrane pH catheter electrode for intraluminal measurements in the upper gastrointestinal tract
1987
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection
1987
Systematic Review: Strategies for Using Exercise Therapy To Improve Outcomes in Chronic Low Back Pain
2005
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Exercise therapy for treatment of non-specific low back pain
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.
1990 StandoutNobel
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
2003 Standout
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Motor control exercise for chronic non-specific low-back pain
2016
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Interleukin-1 and interleukin-1 antagonism
1991 Standout
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001
Works of Lars Remvig being referenced
The effect of antacid on gastric and duodenal bulb acidity.
1980
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION
1992
Exercises for Chronic Low Back Pain: A Clinical Trial
1995
Biological assays for interleukin 1 detection
1991
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials
1996
Effect of Auranofin and Sodium Aurothiomalate on lnterleukin-1 Production from Human Monocytes In Vitro
1988
Interleukin 1 Activity in the Acquired Immunodeficiency Syndrome
1986